Kathleen Goetz bought $2,506 of THW
director at abrdn World Healthcare Fund. 200 shares at an average of $12.53, traded Apr 9, 2024, filed Apr 12, 2024.
Score components
- +15RoleDirector
- 0Trade size$3k at market
- +6Relative to holdingsHoldings up 24%
- 0Price contextNear the top of the 52-week range
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +6.9%, 3m +12.2%, 6m +12.0%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-24-046551, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 9, 2024 | POpen-market purchase Common Stock | +200 | $12.53 | $2,506 | 1,017 | Apr 12, 2024 |
Related signals
Other insiders at abrdn World Healthcare Fund and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | THWbuy abrdn World Healthcare Fund | Chris LaVictoire Mahai director | $11k 796 shares | - | |
| 23Weak | THWbuy abrdn World Healthcare Fund | Bill Maher director | $13k 1,000 shares | - | |
| 23Weak | THWbuy abrdn World Healthcare Fund | Rose DiMartino director | $13k 1,000 shares | - | |
| 23Weak | THWbuy abrdn World Healthcare Fund | Todd Reit director | $12k 1,000 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.